Introduction {#S1}
============

Human neurodevelopment requires coordinated expression of thousands of genes, exquisitely regulated in both spatial and temporal dimensions, to achieve the proper specialization and inter-connectivity of brain regions. Consequently, the dysregulation of complex gene networks in the developing brain is thought to underlie many neurodevelopmental and psychiatric disorders ([@R1]). In order to understand these pathologic gene expression changes, it is critical to achieve a comprehensive understanding of normal gene expression *regulation* throughout human neurodevelopment. While broad surveys of gene expression across the developing human brain have recently been described ([@R2]), the molecular regulators of this gene expression\--most notably microRNAs\-- have only been assessed in a few brain regions or developmental periods ([@R3]--[@R6]). As microRNAs are increasingly recognized in fundamental brain developmental processes and neurologic diseases ([@R7]), a comprehensive understanding of their expression dynamics throughout human brain development is important.

Therefore, we analyzed the differential expression of all microRNAs (miRNAs) detected by RNA-sequencing of 82 neurologically-normal post-mortem human brain tissue samples, which derived from 18 individual donor brains spanning 4 months through 19 years of age (see Methods). Donor samples were grouped into four developmental time windows (infancy, early childhood, late childhood, and adolescence, [Table 1](#T1){ref-type="table"}). Six distinct brain regions were assessed: four regions of the prefrontal cortex, the hippocampus, and the cerebellum. We also assessed for differential miRNA expression between males and females in the prefrontal cortex. Then, we identified putative gene targets of the differentially expressed miRNAs, determined if these gene targets were enriched for particular functional processes, and finally assessed if the identified targets were enriched for genes associated with common neurodevelopmental, psychiatric, and neurodegenerative diseases.

Methods {#S2}
=======

miRNA Data and Pre-processing {#S3}
-----------------------------

All data was obtained from the Allen Institute for Brain Science *BrainSpan* Atlas of the Developing Human Brain ([www.brainspan.org](http://www.brainspan.org)). Details of tissue acquisition, processing, and RNA-sequencing can be found on the *BrainSpan* website. Data was downloaded at: [download.alleninstitute.org/brainspan/MicroRNA](http://download.alleninstitute.org/brainspan/MicroRNA). The full dataset contained 1620 miRNAs measured across 215 brain samples. Only brain samples originating from the orbitofrontal prefrontal cortex (OFC; Brodmann's Area (BA) 11), dorsolateral prefrontal cortex (DFC; BA 9, 46), medial prefrontal cortex (MFC; BA 32, 33, 34), ventrolateral prefrontal cortex (VFC; BA 44,45), hippocampus (HIP), or cerebellum (CER) were retained (82 total samples, [Supplementary Table 11](#SD1){ref-type="supplementary-material"}). For analysis between sexes, brain regions were aggregated from the prefrontal cortex samples. Next, miRNAs with read counts likely to be noise rather than true reads were removed, in order to increase subsequent statistical power; this has been demonstrated not to affect the dispersion model used to calculate differential expression ([@R8]). Importantly, we did this prior to any analysis of the data. To do so, the sum total of read counts for each miRNA across all 82 samples was calculated. miRNAs with zero total reads were immediately discarded (58 miRNAs). Next, miRNAs were ordered from most to least reads (range 1 to 41,540,463) and the dispersion of read counts was plotted for visualization. Then, any miRNA with a total read count less than 60 was discarded, resulting in 902 retained miRNAs ([Supplementary Table 11](#SD1){ref-type="supplementary-material"}).

miRNA Differential Expression Analysis {#S4}
--------------------------------------

Differentially expressed miRNAs were discovered using the edgeR package ([@R9]) run in the R programming environment. The edgeR user guide was followed as detailed in the "classic analysis" section. We chose this method to evaluate differential expression because its performance is intermediately conservative among various RNA-seq analysis packages ([@R10]). miRNAs were considered to be significantly differentially expressed between groups only if the false discovery rate (FDR) p-value was \< 0.05 and the absolute log~2~ of Fold Change (FC) was \> 1.5. Differentially expressed miRNAs were identified across three dimensions: spatial, temporal, and by sex. Spatial miRNAs were differentially expressed between two anatomic brain regions within one developmental time period. Temporal miRNAs were differentially expressed over developmental time within the one anatomic brain region. Sex-biased miRNAs were differentially expressed between male and female prefrontal cortex samples within one time period (data was combined from all four prefrontal cortex regions).

Downstream analysis of miRNA targets {#S5}
------------------------------------

miRNAs that were determined to be differentially expressed temporally or by sex were further analyzed for putative target genes under their control. To do so, we used the target prediction algorithms of TargetScanHuman 6.2 ([@R11]) and miRDB ([@R12]). We considered as significant only those targets that were predicted by both algorithms. Gene ontology (GO) enrichment analysis of the target genes was performed using DAVID Bioinformatics Resources 6.7 Functional Annotation Tool ([@R13]). Gene ontologies were considered significant only if their Benjamini-Hochberg multiple testing corrected p-value was \< 0.05. GO enrichment analysis was performed on lists of aggregated targets (all time periods) that were brain region specific.

Test for enrichment of disease-associated genes {#S6}
-----------------------------------------------

To determine if the target genes of differentially expressed miRNAs may relate to neurological diseases, we assessed for their enrichment into disease-related gene sets. Disease related gene sets were downloaded from the Genotator database ([@R14]). Enrichment was tested using the Hypergeometric probability distribution function in Excel. The population universe (i.e. all protein-coding genes in the human genome) was set to 20,687 ([@R15]). A success in the Hypergeometric function test was a gene that was both a predicted miRNA target and previously associated with a disorder. P-values were corrected for multiple testing by applying the conservative Bonferorri method. Enrichment was only considered significant if the Bonferorri-corrected p-value was \< 0.01.

Results and Discussion {#S7}
======================

In total, we discovered 75 miRNAs differentially expressed across developmental time *within* brain regions (absolute log~2~. fold change \> 1.5 and FDR \< 0.05, [Supplementary Table 1](#SD1){ref-type="supplementary-material"}). Similar to previously described changes in gene expression, the greatest differential expression of miRNAs occurred during the transition from infancy to early childhood ([Figure 1](#F1){ref-type="fig"}). The dorsolateral prefrontal cortex exhibited the greatest number of differentially expressed miRNAs (35 miRNAs) and the cerebellum a similar amount (22 miRNAs); the hippocampus and other regions of the prefrontal cortex each displayed less than five differentially expressed miRNAs. In contrast, differential expression of miRNAs *between* brain regions increased over developmental time ([Figure 2](#F2){ref-type="fig"}, [Supplementary Table 2](#SD1){ref-type="supplementary-material"}). This finding is opposite previously described patterns of mRNA expression, which has been shown to become more globally similar between brain regions over development ([@R2]).

As many neurodevelopmental disorders display a significant sex-bias in their prevalence ([@R16]--[@R18]), we also assessed for differential miRNA expression by sex in the prefrontal cortex. We discovered 40 miRNAs with significant sex-biased expression differences between the prefrontal cortex of males and females ([Table 2](#T2){ref-type="table"}, [Supplementary Table 3](#SD1){ref-type="supplementary-material"}). Strikingly, 93% were more highly expressed in females, again a trend opposite to that of sex-biased gene expression ([@R2]). Furthermore, the majority of sex-biased gene expression occurred in adolescence (65%), suggesting that miRNA-targeted gene expression differences in the prefrontal cortex of males versus females becomes most pronounced around puberty.

To explore the potential biologic and pathogenic roles of the differentially expressed miRNAs, we identified putative targets of the temporally and sex-biased differentially expressed miRNAs (see Methods, [Supplementary Table 4](#SD1){ref-type="supplementary-material"}). We then assessed for enrichment of gene ontology (GO) categories in all lists of putative target genes. Overall, miRNA target genes were highly related to the process of transcription regulation in almost all lists ([Supplementary Tables 5--10](#SD1){ref-type="supplementary-material"}). This finding is in line with the well-known function of miRNAs as master regulators of gene expression networks ([@R19], [@R20]), and underscores the importance of identifying these key hubs of brain transcriptomes. Additionally, putative gene target lists were enriched for biological processes relating to nervous system development, synaptogenesis, and other basic intracellular processes.

Of particular note was the functional enrichment of miRNA targets that were differentially expressed between male and female prefrontal cortex. In addition to the processes implicated in all lists, the sex-biased targets were further enriched for Wnt signaling and transforming growth factor-beta (TGF-β) pathways. This result suggests these pathways may partially underlie normal behavioral differences in executive functioning between males and females. Furthermore, these two pathways are implicated in neurological disorders with sex-biased differences in prevalence ([@R21], [@R22]), and therefore may relate this sex disparity to underlying miRNA expression differences during normal brain development.

Last, we assessed for enrichment of miRNA targets among genes previously implicated in various neurological and psychiatric disorders that have significant genetic etiology (see Methods). We tested for enrichment of genes involved in epilepsy, three neurodevelopmental disorders (autism, schizophrenia, and bipolar disease), three neurodegenerative disorders (Alzheimer's, Huntington's, and Parkinson's diseases), and three psychiatric diseases (major depressive disorder, post-traumatic stress disorder, and obsessive-compulsive disorder). The enrichment of all gene lists significant for various disorders is shown in [Figures 3](#F3){ref-type="fig"} and [4](#F4){ref-type="fig"}. The three neurodevelopmental disorders (ASD, Schizophrenia, and Bipolar) showed a nearly identical enrichment pattern, among many categories. In contrast, there was almost no enrichment for neurodegenerative disease lists. Similarly, the neuropsychiatric disorders showed no enrichment for miRNA target genes, except for major depressive disorder, where the pattern was similar to the neurodevelopmental disorders.

In summary, we describe the most comprehensive assessment to date of spatio-temporal miRNA expression in the developing human brain. Our results identified miRNAs differentially expressed both within and between brain regions, and demonstrated that the greatest shifts in miRNA expression occur shortly after birth. However, unlike global gene expression patterns, miRNAs become more differentially expressed between brain regions over time, potentially driving regional specialization as the brain matures. Target genes under putative control by region-specific differentially expressed miRNAs are most related to the processes of transcription regulation and neurodevelopment, highlighting the central function of these miRNAs to brain transcription networks. Additionally, sex-biased expression of miRNAs increases in the prefrontal cortex around puberty, and the pathways related to sex-biased target genes are further enriched for Wnt signaling and TGF-β pathways. Common neurodevelopmental disorders with complex genetic etiologies are highly related to genes targeted by these miRNAs, but this was not found for genes related to neurodegenerative or other neuropsychiatric diseases with adult onset.

This study has a number of important limitations. First, the total sample size is 18 donor brains, potentially limiting the statistical power. Unfortunately, this problem is prevalent throughout human neurosciences research owing to the lack of large repositories of human post mortem brain tissue ([@R23]). Therefore, it will be important for future studies to replicate and aggregate the data presented here with larger datasets when they become available. Additionally, while computational prediction of miRNA targets based on sequence homology is an effective discovery tool, individual miRNAs of interest will require *in vitro* or *in vivo* experimental validation of their targets.

In conclusion, while thousands of genes are differentially expressed throughout human neurodevelopment, we have identified a set of miRNAs with differential spatio-temporal and sex-biased expression patterns that may regulate these expression changes. The targets of these differentially expressed miRNAs are highly enriched for genes related to transcriptional regulation, neurodevelopmental processes, and common neurodevelopmental disorders. Furthermore, inter-regional expression differences of miRNAs appear to increase over development. These results suggest the identified miRNAs are likely hubs of critical brain developmental and pathologic transcriptional processes.
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![Number of differentially expressed miRNAs between brain regions over development\
Light blue represents the prefrontal cortex, green represents the hippocampus, and the cerebellum is shaded in brown.](nihms498343f2){#F2}
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Dashed line indicates significance (corrected p-value \< 0.01).](nihms498343f3){#F3}
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###### 

Developmental periods and average number of donor tissue samples assessed.

  Developmental Period   Ages                 Avg. Samples per Region
  ---------------------- -------------------- -------------------------
  **Infancy**            4 months -- 1 year   3.5
  **Early Childhood**    2 -- 4 years         3.0
  **Late Childhood**     8 -- 13 years        2.8
  **Adolescence**        15 -- 23 years       4.3

###### 

Differentially expressed miRNAs between male and female prefrontal cortex over development.

                        Up-regulated in Males   Up-regulated in Females   Total
  --------------------- ----------------------- ------------------------- --------
  **Infancy**           1                       1                         2
  **Early Childhood**   1                       9                         10
  **Late Childhood**    0                       2                         2
  **Adolescence**       1                       25                        26
  **Total**             3                       37                        **40**
